Borgeson Blake
Director at RXRX
- Sold, on record
- $10.6M
- Dollars the filings state
- Form 4 sales
- 67
- Latest Oct 6, 2026
- Form 144 notices
- 53
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RXRXRECURSION PHARMACEUTICALS, INC.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice RXRXNoticeJul 7, 2026 2026
Filed to sell 40,000 shares ($159k)
Borgeson Blake, Director
10b5-1 plan3.5x usual sizeFiling
- 2 Form 4 sale RXRXUnusualJul 7, 2026 same day
Sold 40,000 shares at $3.96 ($158k)
Borgeson Blake, Director
10b5-1 planSold 0.6% of holdings ($24.8M position)6.2M shares left3.5x usual sizeFollows a Form 144Filing
- 3 Form 144 notice RXRXNoticeAug 4, 2026 +28 days
Filed to sell 30,000 shares ($98k)
Borgeson Blake, Director
10b5-1 plan1.4x usual sizeFiling
- 4 Form 4 sale RXRXRoutineAug 4, 2026 same day
Sold 30,000 shares at $3.25 ($98k)
Borgeson Blake, Director
10b5-1 planSold 0.5% of holdings ($20.2M position)6.2M shares left1.4x usual sizeFollows a Form 144Filing
- 5 Form 144 notice RXRXNoticeSep 1, 2026 +28 days
Filed to sell 30,000 shares ($100k)
Borgeson Blake, Director
10b5-1 plan1x usual sizeFiling
- 6 Form 4 sale RXRXRoutineSep 1, 2026 same day
Sold 30,000 shares at $3.34 ($100k)
Borgeson Blake, Director
10b5-1 planSold 0.5% of holdings ($20.7M position)6.2M shares left1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice RXRXNoticeOct 6, 2026 +35 days
Filed to sell 50,000 shares ($242k)
Borgeson Blake, Director
10b5-1 plan1.7x usual sizeFiling
- 8 Form 4 sale RXRXRoutineOct 6, 2026 same day
Sold 50,000 shares at $4.84 ($242k)
Borgeson Blake, Director
10b5-1 planSold 0.8% of holdings ($29.8M position)6.1M shares left1.7x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (120)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Oct 7, 2026 | RXRX | Director | Form 4 sale | 50,000 | $242k | 0.8% | Routine | SEC |
| Oct 6, 2026 | Oct 6, 2026 | RXRX | Director | Form 144 notice | 50,000 | $242k | Notice | SEC | |
| Sep 1, 2026 | Sep 2, 2026 | RXRX | Director | Form 4 sale | 30,000 | $100k | 0.5% | Routine | SEC |
| Sep 1, 2026 | Sep 1, 2026 | RXRX | Director | Form 144 notice | 30,000 | $100k | Notice | SEC | |
| Aug 4, 2026 | Aug 6, 2026 | RXRX | Director | Form 4 sale | 30,000 | $98k | 0.5% | Routine | SEC |
| Aug 4, 2026 | Aug 4, 2026 | RXRX | Director | Form 144 notice | 30,000 | $98k | Notice | SEC | |
| Jul 7, 2026 | Jul 9, 2026 | RXRX | Director | Form 4 sale | 40,000 | $158k | 0.6% | Unusual | SEC |
| Jul 7, 2026 | Jul 7, 2026 | RXRX | Director | Form 144 notice | 40,000 | $159k | Notice | SEC | |
| Jun 2, 2026 | Jun 4, 2026 | RXRX | Director | Form 4 sale | 30,000 | $110k | 0.5% | Routine | SEC |
| Jun 2, 2026 | Jun 2, 2026 | RXRX | Director | Form 144 notice | 30,000 | $110k | Notice | SEC | |
| May 5, 2026 | May 7, 2026 | RXRX | Director | Form 4 sale | 30,000 | $106k | 0.5% | Routine | SEC |
| May 5, 2026 | May 5, 2026 | RXRX | Director | Form 144 notice | 30,000 | $106k | Notice | SEC | |
| Apr 7, 2026 | Apr 8, 2026 | RXRX | Director | Form 4 sale | 30,000 | $93k | 0.5% | Routine | SEC |
| Apr 7, 2026 | Apr 7, 2026 | RXRX | Director | Form 144 notice | 30,000 | $93k | Notice | SEC | |
| Mar 3, 2026 | Mar 4, 2026 | RXRX | Director | Form 4 sale | 170,000 | $588k | 2.6% | Unusual | SEC |
| Mar 3, 2026 | Mar 3, 2026 | RXRX | Director | Form 144 notice | 170,000 | $588k | Notice | SEC | |
| Feb 3, 2026 | Feb 6, 2026 | RXRX | Director | Form 4 sale | 220,000 | $924k | 3.3% | Unusual | SEC |
| Feb 3, 2026 | Feb 3, 2026 | RXRX | Director | Form 144 notice | 220,000 | $924k | Notice | SEC | |
| Jan 6, 2026 | Jan 8, 2026 | RXRX | Director | Form 4 sale | 220,000 | $959k | 3.2% | Unusual | SEC |
| Jan 6, 2026 | Jan 6, 2026 | RXRX | Director | Form 144 notice | 220,000 | $959k | Notice | SEC | |
| Dec 2, 2025 | Dec 4, 2025 | RXRX | Director | Form 4 sale | 220,000 | $961k | 3.1% | Unusual | SEC |
| Dec 2, 2025 | Dec 2, 2025 | RXRX | Director | Form 144 notice | 220,000 | $961k | Notice | SEC | |
| Nov 12, 2024 | Nov 14, 2024 | RXRX | Director | Form 4 sale | 11,447 | $87k | 0.2% | Routine | SEC |
| Nov 12, 2024 | Nov 12, 2024 | RXRX | Director | Form 144 notice | 11,447 | $87k | Notice | SEC | |
| Oct 29, 2024 | Oct 31, 2024 | RXRX | Director | Form 4 sale | 11,447 | $77k | 0.2% | Routine | SEC |
| Oct 29, 2024 | Oct 29, 2024 | RXRX | Director | Form 144 notice | 11,447 | $77k | Notice | SEC | |
| Oct 15, 2024 | Oct 17, 2024 | RXRX | Director | Form 4 sale | 11,447 | $76k | 0.2% | Routine | SEC |
| Oct 15, 2024 | Oct 15, 2024 | RXRX | Director | Form 144 notice | 11,447 | $76k | Notice | SEC | |
| Oct 1, 2024 | Oct 3, 2024 | RXRX | Director | Form 4 sale | 11,447 | $71k | 0.2% | Routine | SEC |
| Oct 1, 2024 | Oct 1, 2024 | RXRX | Director | Form 144 notice | 11,447 | $75k | Notice | SEC | |
| Sep 17, 2024 | Sep 19, 2024 | RXRX | Director | Form 4 sale | 11,447 | $78k | 0.2% | Routine | SEC |
| Sep 17, 2024 | Sep 17, 2024 | RXRX | Director | Form 144 notice | 11,447 | $78k | Notice | SEC | |
| Sep 3, 2024 | Sep 5, 2024 | RXRX | Director | Form 4 sale | 11,447 | $72k | 0.2% | Routine | SEC |
| Sep 3, 2024 | Sep 3, 2024 | RXRX | Director | Form 144 notice | 11,447 | $72k | Notice | SEC | |
| Aug 20, 2024 | Aug 22, 2024 | RXRX | Director | Form 4 sale | 11,447 | $82k | 0.2% | Routine | SEC |
| Aug 20, 2024 | Aug 20, 2024 | RXRX | Director | Form 144 notice | 11,447 | $82k | Notice | SEC | |
| Aug 6, 2024 | Aug 8, 2024 | RXRX | Director | Form 4 sale | 11,447 | $78k | 0.2% | Routine | SEC |
| Aug 6, 2024 | Aug 6, 2024 | RXRX | Director | Form 144 notice | 11,447 | $78k | Notice | SEC | |
| Jul 23, 2024 | Jul 25, 2024 | RXRX | Director | Form 4 sale | 11,447 | $97k | 0.2% | Routine | SEC |
| Jul 23, 2024 | Jul 23, 2024 | RXRX | Director | Form 144 notice | 11,447 | $97k | Notice | SEC | |
| Jul 9, 2024 | Jul 11, 2024 | RXRX | Director | Form 4 sale | 11,447 | $84k | 0.2% | Routine | SEC |
| Jul 9, 2024 | Jul 9, 2024 | RXRX | Director | Form 144 notice | 11,447 | $84k | Notice | SEC | |
| Jun 25, 2024 | Jun 27, 2024 | RXRX | Director | Form 4 sale | 11,447 | $109k | 0.2% | Routine | SEC |
| Jun 25, 2024 | Jun 25, 2024 | RXRX | Director | Form 144 notice | 11,447 | $109k | Notice | SEC | |
| Jun 11, 2024 | Jun 13, 2024 | RXRX | Director | Form 4 sale | 11,447 | $97k | 0.2% | Routine | SEC |
| Jun 11, 2024 | Jun 11, 2024 | RXRX | Director | Form 144 notice | 11,447 | $97k | Notice | SEC | |
| May 28, 2024 | May 30, 2024 | RXRX | Director | Form 4 sale | 11,447 | $105k | 0.2% | Routine | SEC |
| May 28, 2024 | May 28, 2024 | RXRX | Director | Form 144 notice | 11,447 | $105k | Notice | SEC | |
| May 14, 2024 | May 16, 2024 | RXRX | Director | Form 4 sale | 20,054 | $203k | 0.3% | Routine | SEC |
| May 14, 2024 | May 14, 2024 | RXRX | Director | Form 144 notice | 20,054 | $203k | Notice | SEC |